NDC 17856-0138-01 - Lidocaine hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0138
- Requested NDC
- 17856-0138-01
- Package NDCs from labels
- 17856-0138-3, 17856-0138-1, 17856-0138-4, 17856-0138-2, 17856-0138-6, 17856-0138-5, 17856-0138-01
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-05-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lidocaine Hydrochloride Oral Topical Solution USP, 2% (Viscous) | ATLANTIC BIOLOGICALS CORP. | 2025-05-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0138-1 | Lidocaine hydrochloride | 50 in 1 BOX, UNIT-DOSE | SOLUTION | 50 | 3 | |
| 17856-0138-2 | Lidocaine hydrochloride | 50 in 1 BOX, UNIT-DOSE | SOLUTION | 50 | 3 | |
| 17856-0138-3 | Lidocaine hydrochloride | 15 mL in 1 CUP, UNIT-DOSE | SOLUTION | 15 | 3 | |
| 17856-0138-4 | Lidocaine hydrochloride | 20 mL in 1 CUP, UNIT-DOSE | SOLUTION | 20 | 3 | |
| 17856-0138-5 | Lidocaine hydrochloride | 72 in 1 BOX, UNIT-DOSE | SOLUTION | 72 | 3 | |
| 17856-0138-6 | Lidocaine hydrochloride | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0138 | LIDOCAINE HYDROCHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORP.] | 3 | Current NDC, 6 package rows | 20250514_75d17334-6876-42d0-8a02-82669d139e4f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0138-1 | ML - Milliliter | 17856-0138 | c494c261-df59-4696-919e-e062bcc63ab6 | 1 | 2024-03-12 |
| 17856-0138-2 | ML - Milliliter | 17856-0138 | c72c7dce-4880-4309-b60c-c5d0f465dce5 | 1 | 2024-03-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Safetec of America, Inc. | 1c5eb3b3-79b3-472a-ae36-ec6a7dc72925 | 2024-02-07 | Warnings | V13007Z41A |
| Antiseptic | ALCOHOL, LIDOCAINE HYDROCHLORIDE | Safetec of America, Inc. | 71aeaf86-2b4d-4945-9606-a9db0ab6b726 | 2024-02-07 | Warnings | V13007Z41A |
| First Aid and Burn | BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE | Safetec of America, Inc. | 47cb6921-5d82-4123-a9e0-0b05d4dcb5b2 | 2024-02-07 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Safetec of America, Inc. | 8eb3e7e2-26e5-430e-89aa-40a0367c637e | 2024-02-07 | Warnings | V13007Z41A |
| Sterile Water | STERILE WATER | Chartwell RX, LLC | 3681eeaa-807a-47ca-9fbc-61c2b682800a | 2024-02-01 | 059QF0KO0R | |
| Sterile Water | WATER | A-S Medication Solutions | dba87371-31d2-47c2-ab83-89aabce4b184 | 2024-01-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Mirakel Pain Relief Roll-On | LIDOCAINE HCL | Sanvio, Inc. | 102f3618-13ad-37e3-e063-6294a90a8086 | 2024-01-30 | Warnings | V13007Z41A |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 8c63be55-5de4-7f72-e053-2995a90a102e | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| 1% LIDOCAINE HCI | 1% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 999dd95d-87fe-12c0-e053-2995a90aa9f7 | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | c4bf5905-add7-1cb0-e053-2995a90a7334 | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | c4c0df51-cc37-323d-e053-2995a90a154a | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | 7a664a34-19fd-4a7b-ab4d-11299b32999e | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | fd6343a9-15a6-4894-b51f-122e4d6dbe79 | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Seton Pharmaceuticals | 1c0abe84-5404-404e-b882-e910e4d43ffb | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | 951862db-3a73-4d25-9d5b-e4111833f43b | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | 6aa284d6-0212-4fb5-809d-c721aa6fe2ba | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 993bc59e-5e71-bd9e-e053-2a95a90af85c | 2024-01-28 | Warnings, Adverse reactions | V13007Z41A |
| 2% LIDOCAINE HCI | 2% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 78d8fb0a-bfae-6599-e053-2991aa0a2e03 | 2024-01-28 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCl | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | c4c16714-6b1f-857e-e053-2a95a90a74e4 | 2024-01-28 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | c901016e-9293-79dd-e053-2a95a90a0fda | 2024-01-27 | Warnings, Adverse reactions | V13007Z41A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.